Real-world osimertinib for EGFR mutation-positive non-small-cell lung cancer with acquired T790M mutation

Future Oncology, Ahead of Print.

Source: Future Oncology - July 13, 2020 Category: Cancer & Oncology Authors: Fumio Imamura Madoka Kimura Yukihiro Yano Masahide Mori Hidekazu Suzuki Tomonori Hirashima Shouichi Ihara Kiyoshi Komuta Takayuki Shiroyama Izumi Nagatomo Toru Kumagai Source Type: research